180 related articles for article (PubMed ID: 33958279)
21. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
[TBL] [Abstract][Full Text] [Related]
22. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
[TBL] [Abstract][Full Text] [Related]
23. Genetic Association With
Nourkami-Tutdibi N; Freitag K; Zemlin M; Tutdibi E
Front Immunol; 2021; 12():587313. PubMed ID: 33679736
[No Abstract] [Full Text] [Related]
24. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.
Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M
J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966
[TBL] [Abstract][Full Text] [Related]
25. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.
McCoy KS; Quittner AL; Oermann CM; Gibson RL; Retsch-Bogart GZ; Montgomery AB
Am J Respir Crit Care Med; 2008 Nov; 178(9):921-8. PubMed ID: 18658109
[TBL] [Abstract][Full Text] [Related]
26. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
[TBL] [Abstract][Full Text] [Related]
27. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.
Volkova N; Moy K; Evans J; Campbell D; Tian S; Simard C; Higgins M; Konstan MW; Sawicki GS; Elbert A; Charman SC; Marshall BC; Bilton D
J Cyst Fibros; 2020 Jan; 19(1):68-79. PubMed ID: 31196670
[TBL] [Abstract][Full Text] [Related]
28. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
Ren CL; Konstan MW; Yegin A; Rasouliyan L; Trzaskoma B; Morgan WJ; Regelmann W;
J Cyst Fibros; 2012 Jul; 11(4):293-9. PubMed ID: 22445849
[TBL] [Abstract][Full Text] [Related]
29. Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data.
Frost FJ; Nazareth DS; Charman SC; Winstanley C; Walshaw MJ
Ann Am Thorac Soc; 2019 Nov; 16(11):1375-1382. PubMed ID: 31319678
[No Abstract] [Full Text] [Related]
30. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
32. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
[TBL] [Abstract][Full Text] [Related]
33. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR
Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301
[TBL] [Abstract][Full Text] [Related]
34. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis.
VanDevanter DR; Heltshe SL; Hilliard JB; Konstan MW
J Cyst Fibros; 2021 Mar; 20(2):257-263. PubMed ID: 32505525
[TBL] [Abstract][Full Text] [Related]
37. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study.
de Dios Caballero J; Del Campo R; Royuela A; Solé A; Máiz L; Olveira C; Quintana-Gallego E; de Gracia J; Cobo M; de la Pedrosa EG; Oliver A; Cantón R;
J Cyst Fibros; 2016 May; 15(3):357-65. PubMed ID: 26429520
[TBL] [Abstract][Full Text] [Related]
38. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.
Demko CA; Byard PJ; Davis PB
J Clin Epidemiol; 1995 Aug; 48(8):1041-9. PubMed ID: 7775991
[TBL] [Abstract][Full Text] [Related]
40. Long-term clinical outcomes of 'Prairie Epidemic Strain'
Somayaji R; Lam JC; Surette MG; Waddell B; Rabin HR; Sibley CD; Purighalla S; Parkins MD
Thorax; 2017 Apr; 72(4):333-339. PubMed ID: 27682327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
